Literature DB >> 3548512

Shortened endotoxin-activated clotting times in patients with carcinoma.

C R Spillert, E J Lazaro.   

Abstract

Isolated human monocytes generate tissue factor when stimulated with endotoxins. This tissue factor generation provides a convenient marker of monocyte activation. Furthermore, the only circulating blood cell capable of generating large quantities of tissue factor is the monocyte. Therefore, the addition of endotoxin to citrated blood, and the determination of the recalcification times after incubation, yields a measure of monocyte activation. In order to determine whether monocyte activation as measured by this technique varies between patients with carcinoma and healthy volunteers, recalcification times were evaluated. The recalcification time and range for 19 healthy volunteers (controls) was 6.55 min (5.3-8.5) for the saline incubated sample and 5.69 min (4.6-7.2) for the endotoxin-activated sample. The results for 13 patients with carcinoma are 4.81 min (3.3-6.3) for the former and 3.17 min (2.0-4.3) for the latter. These results show that the longest recalcification time with endotoxin incubation for patients with carcinoma was lower than the lowest recalcification time in the control group. Whether this simple test can be of use in the diagnosis and monitoring of patients with carcinomas is currently being investigated.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3548512

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  8 in total

1.  Effect of methylprednisolone on coagulation.

Authors:  H B Pandit; C R Spillert
Journal:  J Natl Med Assoc       Date:  1999-08       Impact factor: 1.798

2.  Modified recalcification time (MRT): a sensitive cancer test? Review of the evidence.

Authors:  C R Spillert; E J Lazaro
Journal:  J Natl Med Assoc       Date:  1995-09       Impact factor: 1.798

3.  Recalcification time in breast disease.

Authors:  C A Sofia; C R Spillert; J A Pastena; E J Lazaro
Journal:  J Natl Med Assoc       Date:  1988-11       Impact factor: 1.798

4.  Altered coagulability: an aid to selective breast biopsy.

Authors:  C R Spillert; M R Passannante; J E Salzer-Pagan; E J Lazaro
Journal:  J Natl Med Assoc       Date:  1993-04       Impact factor: 1.798

5.  In vitro effect of hirudin on recalcification time.

Authors:  J Hirsh; C R Spillert; E P Delle Donne; E J Lazaro
Journal:  J Natl Med Assoc       Date:  1994-08       Impact factor: 1.798

6.  Hypertension-related coronary thrombosis: prothrombic role of angiotensin II.

Authors:  C R Spillert; S Sun; M A Miller; E J Lazaro
Journal:  J Natl Med Assoc       Date:  1994-09       Impact factor: 1.798

7.  Prediction of clinical course in diabetes using a simple coagulation test.

Authors:  C R Spillert; V J Milazzo; J A Pastena; E J Lazaro
Journal:  J Natl Med Assoc       Date:  1989-01       Impact factor: 1.798

8.  Modified recalcification time: a global coagulation screening test.

Authors:  C R Spillert; E J Lazaro
Journal:  J Natl Med Assoc       Date:  1993-08       Impact factor: 1.798

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.